Clinical Trials
37 trialsEF-41
NovoCure Ltd.
BRIDGES
GT Medical Technologies, Inc.
SONOBIRD
CarThera
IPAX BrIGHT
Telix Pharmaceuticals (Innovations) Pty Limited
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of AvastinĀ® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
NaviFUS Corporation
SIGMA
Nuvation Bio Inc.
Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
GC Cell Corporation
STAR-3
Kintara Therapeutics, Inc.
CSCRGBM
Cordgenics, LLC
CheckMate 143
Bristol-Myers Squibb
Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
Ascletis Pharma Inc
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
Denovo Biopharma LLC
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Precision Life Sciences Group
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Sumitomo Pharma America, Inc.
Intellance1
AbbVie
GBM
Northwest Biotherapeutics
INTACT
Diffusion Pharmaceuticals Inc
UNITE Study: Understanding New Interventions With GBM ThErapy
AbbVie
ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
Safe Save Medical Cell Sciences & Technology Co.,Ltd.
Enzastaurin Versus Lomustine in Glioblastoma
Eli Lilly and Company
GLOBE
Vascular Biogenics Ltd. operating as VBL Therapeutics
ACT IV
Celldex Therapeutics
A Study of Bevacizumab (AvastinĀ®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
Hoffmann-La Roche
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
Merck Sharp & Dohme LLC
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
NovoCure Ltd.
REGAL
AstraZeneca
SAPPHIRE
Isarna Therapeutics GmbH
CENTRIC
EMD Serono
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
Pfizer
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
Shandong Lanjin Pharmaceuticals Co.,Ltd
Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
NovoCure Ltd.
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
INSYS Therapeutics Inc
Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
Novartis
Glass-Art
Bradmer Pharmaceuticals Inc.
Study of Therapy With TransMID⢠Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
Xenova Biomedix
Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
Pfizer